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Necrotizing enterocolitis (NEC) is a serious disease of the intestinal tract affecting 5–10%
of pre-term infants with up to 50% mortality in those that require surgery. There is wide
variation in the rates and outcomes of NEC by race and ethnicity, and the reasons
for this disparity are poorly understood. In this article, we review the epidemiology
and discuss possible explanations for racial and ethnic differences in NEC. Most of
the current evidence investigating the role of race in NEC comes from North America
and suggests that Hispanic ethnicity and non-Hispanic Black race are associated with
higher risk of NEC compared to non-Hispanic White populations. Differences in pre-term
births, breastfeeding rates, and various sociodemographic factors does not fully account
for the observed disparities in NEC incidence and outcomes. While genetic studies
are beginning to identify candidate genes that may increase or decrease risk for NEC
among racial populations, current data remain limited by small sample sizes and lack of
validation. Complex interactions between social and biological determinants likely underly
the differences in NEC outcomes among racial groups. Larger datasets with detailed
social, phenotypic, and genotypic information, coupled with advanced bioinformatics
techniques are needed to comprehensively understand racial disparities in NEC.
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INTRODUCTION
Necrotizing enterocolitis (NEC) is a devastating inflammatory disease of the intestinal tract that
affects 5–10% of pre-term infants born <1,500 grams at birth. It is the most common cause of
emergency gastrointestinal surgery in the neonatal period and is the leading cause of death in pre-
term infants between 2 weeks and 2 months of age (1, 2). Several risk factors have been implicated
in NEC, including prematurity, small for gestational age, formula feeding, infection, ischemia, host
genetics, and gut dysbiosis (3–5). Race has also been identified as an important risk factor for NEC.
In the clinical risk index tool called GutCheckNEC, non-Hispanic Black or Hispanic race is one
of nine independent risk factors that collectively can help identify infants at risk for developing
NEC (6).
While recent studies suggest that rates of NEC are decreasing, the racial gap in rates and
outcomes of NEC has remained unchanged (7, 8). The reasons for underlying racial differences
in pre-term NEC outcomes are poorly understood. Racial disparities in NEC persist despite
controlling for several sociodemographic factors, suggesting that more complex factors that drive
racial differences in NEC are involved. A more comprehensive understanding of how these factors
interact with each other is needed to craft potential solutions that reduce racial disparities in NEC.
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In this article, we review the epidemiologic evidence behind
racial differences in NEC, discuss possible explanations for these
differences, and examine key questions for future research. This
article will focus on the disparities in NEC outcomes among non-
Hispanic Black, non-Hispanic White, and Hispanic infants in
the United States, as these populations are the best studied in
the literature.
EPIDEMIOLOGY OF RACIAL DISPARITIES
IN NEC
Racial Disparities in NEC Across the Globe
Epidemiological studies of NEC from different countries provide
clues regarding the contribution of race in NEC pathogenesis. In
general, NEC appears to occur less frequently among pre-term
infants from Japan, Switzerland, and Austria while afflicting pre-
term infants more often in North America, the United Kingdom,
and Ireland (9). A recent study by Su et al. (10) that compared
outcomes of extremely pre-term infants from Taiwan with those
from other countries found that NEC rates were noticeably lower
in Taiwan (3%) and Japan (3%) compared to Canada (8%) and the
United States (11%). While race may explain these differences,
other reasons such as variations in neonatal care practices can
also explain the marked variation in NEC rates across these
different countries. For example, countries with a more active
approach for offering intensive care to babies at the limits of
viability may have higher NEC rates because of the higher
survival of extreme pre-term babies most at risk for NEC, while
countries with high usage rates of breastmilk or probiotics may
have lower NEC rates (11). Inconsistencies in the criteria used
to define NEC may also make NEC rates vary among different
countries. However, in a systematic review of NEC incidence
from high income countries, Battersby et al. (11) demonstrated
an almost 4-fold difference in NEC rates even among countries
that used Bell staging ≥2 to define NEC.
Racial Disparities in NEC in the
United States
Additional evidence for the role of race in NEC comes from
studies from the United States, where differences in incidence
and severity of NEC based on race were observed in both
single-center and regional studies where care practices and case
definitions for NEC are similar (Table 1).
For example, Guner et al. (16) performed a state-
based analysis of NEC outcomes in California and used
multivariate analysis to demonstrate that Hispanic ethnicity was
independently associated with increased odds of death from
NEC with adjusted odds ratio (aOR) of 1.50 and 95% confidence
interval (CI) of 1.09–2.07. Two more recent studies of infants
from California also showed similar findings of higher odds
of NEC among Hispanics compared to non-Hispanic White
infants (7, 17). Another study by Llanos et al. (14) analyzed
NEC epidemiology from Upstate New York and found that
non-Hispanic Black neonates had significantly higher risk of
NEC compared to non-Hispanic White neonates even after
adjusting for birth weight with relative risk (RR) of 1.70 (95%
CI 1.06–2.61). A more recent study from New York that used a
novel “fetus-at-risk” approach found that non-Hispanic Black
infants had 4.4 times higher rate of NEC (95% CI 2.98–6.51)
compared to non-Hispanic White infants (19).
Studies using US national databases demonstrated racial
differences in NEC as well. An early study by Holman et al.
(13) used data from the National Center for Health Statistics
to study the epidemiology of NEC infant mortality in the
United States and identified that non-Hispanic Black race was
associated with higher mortality rate from NEC compared to
non-Hispanic White race, even after controlling for birth weight,
gestational age, and other characteristics (RR 1.5, 95% CI 1.3–
1.8). Similar findings of increased incidence of NEC in non-
Hispanic Black compared to non-Hispanic White infants were
found in studies using the Kids’ Inpatient Database (15) and
the National Institute of Child Health and Human Development
Neonatal Research Network (12). In a more recent study using
the Pediatrix Medical Group database, Jammeh et al. (18)
demonstrated that non-Hispanic Black and Hispanic infants are
(1) significantly more likely to be diagnosed with NEC, and (2)
have higher odds of death from NEC, compared to non-Hispanic
White infants.
POSSIBLE EXPLANATIONS FOR RACIAL
DISPARITIES IN NEC
Biological Risk Factors That Mediate
Association Between Race and NEC
Racial disparities in NEC can be explained by its strong
association with other biological risk factors known to impact
NEC (Figure 1). For example, prematurity is identified as a
clear and consistent risk factor for NEC. In a 2-year national
surveillance study in England, NEC incidence was 11% among
infants at 24 weeks gestation and decreased to 0.5% at 31 weeks
gestation (20). Another important biologic risk factor for NEC
is low birth weight. In one study from the Netherlands, small
for gestational age infants have more than 2-fold increased
risk for NEC compared to appropriate for gestational age
neonates (21). As rates of pre-term birth and low birth weight
infants are higher among non-Hispanic Black and Hispanic
infants, it has been hypothesized that these factors, rather
than race itself, mediate the higher rates of NEC observed in
this racial population (22, 23). However, several studies that
accounted for differences in birth weight and/or gestational age
found that increased rates of NEC in non-Hispanic Black and
Hispanic infants remained significant even after adjusting for
these confounding factors (7, 13, 14, 16–18). Breastmilk feeding
practices, a major protective factor against NEC, can also vary
among different race groups. Population studies have observed
that breastfeeding rates are lower among non-Hispanic Black
infants compared to non-Hispanic White infants, which may
help to explain the higher NEC rates among non-Hispanic Blacks
(24, 25). The protective effect of breastmilk is highlighted in
the recent study by Goldstein et al. (7) where higher odds of
NEC in non-Hispanic Black infants compared to non-Hispanic
White infants were no longer statistically significant when human
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TABLE 1 | Summary of studies showing racial differences in NEC-related outcomes in the United States.
Study Cohort characteristics Main findings Summary statistics Adjustments to analysis
Uauy et al. (12) 2,681 very low-birth-weight infants
from eight participating University
centers of the National Institute of
Child Health and Human
Development
Increased odds of proven NEC
among non-Hispanic Black
compared to other male infants
aRR 2.3 (1.5–3.4) Center
Holman et al. (13) 6,629 infants who died of NEC based
on data from National Center for
Health Statistics, Centers for Disease
Control and Prevention
Increased NEC-related mortality
among non-Hispanic Black infants
aRR 1.5 (1.3–1.8) Birth weight, sex, maternal
age
Llanos et al. (14) 85 infants with NEC from two regional
perinatal centers in Upstate New York
Increased risk for NEC among
non-Hispanic Black compared to
non-Hispanic White infants
aRR 1.70 (1.06–2.61) Birth weight
Holman et al. (15) 4,463 hospitalizations associated with
NEC were studied using Kids’
Inpatient Database
NEC-related hospitalization rate (per
100,000 live births) higher for
non-Hispanic Blacks than for both






Guner et al. (16) 2,318 infants with NEC from
California Office of Statewide Health
Planning and Development database
Increased mortality among Hispanic
infants with NEC compared to other
ethnicities






245,242 pre-term infants from
California Office of Statewide Health
Planning and Development database
Hispanic infants born at 26–28
weeks’ gestation more likely to
develop NEC than non-Hispanic
White infants
aOR 1.32 (1.05–1.66) Gestational age, birth
weight, sex, multiple
gestation
Jammeh et al. (18) 126,089 infants from Pediatrix
Medical Group database
Increased NEC incidence and NEC
mortality among non-Hispanic Blacks
and Hispanic infants compared to
non-Hispanic White infants
NEC incidence
Non-Hispanic Black: aOR 1.31
(1.25–1.39)
Hispanic: aOR 1.30 (1.21–1.39)
NEC mortality
Non-Hispanic Black: aOR 1.35
(1.15–1.58)
Hispanic: aOR 1.31 (1.09–1.56)
Birth weight, gestational
age, gender, size for





Janevic et al. (19) 582,297 infants from New York State
Department of Health and Human
Services
Increased risk for NEC in










Goldstein et al. (7) 47,112 infants from California
Perinatal Quality Care Collaborative
Increased odds of NEC among
Hispanic and Asian/Pacific Islander
compared to non-Hispanic White
infants.
Hispanic: aOR 1.27 (1.02–1.57)
Asian or Pacific Islander: aOR
1.35 (1.01–1.80)
Birth year, gestational age,
small for gestational age,
multiple birth, Apgar, sex,
required transfer, prenatal
care, level of care, center,
human milk at discharge
aOR, adjusted odds ratio; aHR, adjusted hazards ratio; aRR, adjusted relative risk. Data in parentheses indicate 95% confidence intervals.
milk use was accounted for. In their mediation analysis, human
milk use accounted for 44% of the total risk of NEC in non-
Hispanic Black vs. non-Hispanic White infants. Still, breastmilk
use alone cannot account for the higher rates of NEC among
Hispanics, who typically have higher breastfeeding rates than
non-Hispanic Whites (26). A recent study by Gay et al. (27) also
demonstrated differences in the actual composition of human
milk metabolites among mothers from different countries.
Whether such differences contribute to the differences in NEC
rates among different racial or geographic populations remain
unknown, but it is possible that the differences in breastmilk
metabolites influence the infant’s gut microbiota and mediate
risk for NEC. Another plausible explanation is that because NEC
and death are competing outcomes, the higher risk of neonatal
mortality observed among non-Hispanic White pre-term infants
can explain racial differences in NEC (28). In this hypothesis,
non-Hispanic Black infants have higher NEC rates because of
a greater number of survivors who remain at risk for NEC
(13, 17, 18).
Non-biological Mediators of Racial
Disparities in NEC Outcomes
Race is also a strong proxy for social, cultural, educational,
economic, and environmental experiences – all of which can
influence disease risk (Figure 1). Thus, the observed racial
differences in NEC may be explained by differences in non-
biologic risk factors associated with race. For example, it is
well-documented that Hispanics and non-Hispanic Blacks often
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FIGURE 1 | Schematic diagram showing the interplay between social and biological factors in driving racial disparities in NEC.
have poor access to health care, including prenatal care (29, 30).
Such racial disparities in prenatal care are important as several
maternal factors have been associated with NEC, including
premature rupture of membranes (31), chorioamnionitis (32),
intrauterine growth restriction (33), placental abruption (34),
and inadequate antenatal steroid administration for possible
pre-term delivery (35). In another study, Kogan et al. (36)
analyzed racial disparities in prenatal care and found that non-
Hispanic Black women were more likely to report not receiving
advice about important topics such as breastfeeding – a well-
known protective mediator in NEC (37). Several studies have
also identified inequality in the care of very low birth weight
infants by race, with non-Hispanic Black and Hispanic infants
receiving care at lower-quality hospitals compared to non-
Hispanic White infants (38–41). While the exact reasons for
variation in NEC incidence and outcomes across hospitals are
unclear, clinical practice variables identified in the literature
as potential protective mediators of NEC risk include use of
standardized feeding protocols (42), donor breast milk (43),
antibiotic stewardship (44), and probiotics (45). Other related
variables that can contribute to higher NEC rates include the
over-representation of adverse experiences among non-Hispanic
Black infants such as poverty, malnutrition, stress, pollutants, and
poor education. In addition to their impact on higher pre-term
birth rates (46–48), these adverse experiences may also mediate
racial differences in NEC outcomes through epigenetics and the
microbiome (49, 50).
Genetic Basis of Race-Dependent
Differences in NEC Vulnerability
Another plausible explanation for the observed racial differences
in NEC outcomes is that race imputes an innate biologic
predisposition to NEC (Figure 1). This hypothesis is based on
the assumption that different racial groups have unique patterns
of genetic variations that can increase or decrease inherent risk
for certain diseases (51). Genome wide sequencing studies evince
that non-Hispanic Black populations have more heterozygote
genotypes as well as more non-synonymous variants per
individual compared to other racial populations (52, 53).
Interestingly, selection pressures arising from infectious disease
exposure has resulted in the non-Hispanic Black race having
a stronger inflammatory response to pathogens (54). In adults,
genetic programming of the immune response contributes up to
a 3-fold difference in susceptibility to tuberculosis, septicemia
and inflammatory diseases between non-Hispanic Black and
non-Hispanic White populations (55, 56). Remarkably, NEC
is also postulated to arise from an exaggerated inflammatory
response to gut microbiota, and therefore racial differences in
NEC vulnerability may be genetically programmed (4, 57).
Genetic studies in NEC have often been limited by small
sample sizes and homogenous study populations with little racial
diversity, limiting meaningful subgroup analysis by racial groups.
One study by Franklin et al. (58) evaluated the association of
several pro-inflammatory cytokine gene polymorphisms with
NEC in a racially diverse population of pre-term infants from a
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single center in Washington, DC, and found that non-Hispanic
White neonates with the C allele of IL-6 (rs1800795) were over
6 times more likely to have NEC than those with no C allele
(p = 0.013; OR = 6.61, 95% CI 1.48–29.39). Another study by
Sampath et al. (59) investigated autophagy genes in a multi-
center cohort (n = 1,015) of pre-term infants with and without
NEC and identified that the ATG16L1 (rs2241880, Thr300Ala)
variant was associated with NEC. Risk of NECwas highest among
infants with the AA genotype and decreased proportionately with
the addition of the G allele (AA vs. GG: OR 2.5, 95% CI 1.2–
5.6). In evaluating genetic differences along racial groups, the
authors found that the proportion of infants with the protective
GG allele was lower in non-Hispanic Black infants compared to
non-Hispanic White infants (13 vs. 25%). Similarly, in another
small study, NEC rates were higher in non-Hispanic Black pre-
term infants, and correlated with higher prevalence of the NEC-
associated NFKB1 (g.-24519delATTG) variant in that race (60).
These studies suggest that genetic variants which program
increased inflammation are enriched in certain racial groups and
may explain racial differences in NEC. Yet completion of the
Human Genome Project has highlighted how humans are more
similar than different from each other, and an ongoing debate
remains about the importance of racial differences in genetic
effects for disease (61–63). Comprehensive studies incorporating
genetic, functional and clinical/demographic variables are
required to characterize race-specific susceptible and resilience
genetic factors.
DISCUSSION
While socioeconomic differences between races account for a
substantial portion of racial disparity in health outcomes (64),
adjusting for socioeconomic differences does not completely
eliminate racial disparities in NEC. For example, Guner et
al. (16) evaluated the contribution of household income and
insurance status to differences in mortality from NEC in
California and concluded that these socioeconomic factors could
not explain the disparities in NEC mortality between Hispanic
and non-Hispanic infants. Similarly, Janevic et al. (19) found
that the increased risk among non-Hispanic Black infants for
NEC remained despite including maternal educational level,
insurance level, and other potential socioeconomic factors in
their analysis of pre-term infants from New York. An important
limitation of these studies that adjust for socioeconomic
differences is the potential for unmeasured confounding by
important variables that were not known or recorded in the
original study database (65). Socioeconomic status is also
difficult to measure, and misclassification or measurement
errors in socioeconomic status are not uncommon (66, 67).
Despite these limitations, these studies suggest that while
social factors of race are certainly key contributors, these
factors alone do not account for all the racial differences
in NEC.
The contribution of genetic sequence differences between
racial groups on risk of diseases such as NEC is also poorly
understood (68). Emerging genetic studies of susceptibility
to infection suggest that genetic variations can contribute to
the host-inflammatory immune response (69–71). While some
genetic studies in NEC have shown similar enrichment of pro-
inflammatory genetic variants along racial groups, these studies
should be considered exploratory and hypothesis-generating at
best due to the limited sample size and lack of validation or
functional studies (4, 72). The epigenetic effects of social and
environmental factors on expression of key genes involved in
NEC pathogenesis are also largely unexplored (73–75).
A better understanding of the contribution of race in NEC
pathogenesis is needed to improve the racial disparities in
NEC outcomes. Race is a complex trait that encompasses
several social determinants and may also have important genetic
underpinnings that contribute to NEC. In the search for a better
understanding of how race impacts NEC, it is important to
remember its multifaceted nature and avoid narrowly focusing
on a single aspect while ignoring the rest.
CONCLUSION
There is consistent epidemiological evidence for racial
differences in NEC incidence and severity. While genetic
variations across racial groups may result in biological effects
that impact NEC pathogenesis, current genetic studies remain
inadequate to prove or disprove this hypothesis. Race is
a complex trait encompassing social, cultural, behavioral,
and environmental dimensions that impact health and
disease (76). In exploring racial differences in NEC, it is
important to fully evaluate how both biological and non-
biological aspects of race influence NEC pathogenesis
independently as well as how they interact with each other.
Alongside these research efforts, public health and quality
improvement initiatives should also continue to actively
reduce racial disparities in neonatal and perinatal care to
improve outcomes.
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